SCHEMBL7900675

SCHEMBL7900675

CC(=O)Nc1cccc(-c2nc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc3n2C(C)C)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 13/20 0.61
PIK3R1 P27986 10/20 0.61
MTOR P42345 4/20 0.61
PIK3CD O00329 1/20 0.61
JAK2 O60674 1/20 0.61
JAK1 P23458 1/20 0.61
PIK3CB P42338 1/20 0.61
PIK3CG P48736 1/20 0.61
JAK3 P52333 1/20 0.61
HDAC1 Q13547 7/20 0.44
HDAC3 O15379 4/20 0.44
HDAC4 P56524 4/20 0.44
HDAC7 Q8WUI4 4/20 0.44
HDAC2 Q92769 4/20 0.44
HDAC10 Q969S8 4/20 0.44
HDAC11 Q96DB2 4/20 0.44
HDAC8 Q9BY41 4/20 0.44
HDAC6 Q9UBN7 4/20 0.44
HDAC9 Q9UKV0 4/20 0.44
HDAC5 Q9UQL6 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7902204 0.84 PIK3CA (0.76) PIK3CAPIK3R1MTORPIK3CDJAK2
SCHEMBL4127804 0.79 BRAF (0.56) PIK3CAPIK3R1MTORPIK3CDJAK2
SCHEMBL7902806 0.78 PIK3CA (0.67) PIK3CAPIK3R1MTORPIK3CDJAK2
SCHEMBL7894820 0.77 PIK3CA (0.71) PIK3CAPIK3R1MTORPIK3CDJAK2
Vs-5584 SCHEMBL539098 0.77 PIK3CA (1.00) PIK3CAPIK3R1MTORPIK3CDJAK2
Vs-5584 SCHEMBL29376859 0.77 PIK3CA (1.00) PIK3CAPIK3R1MTORPIK3CDJAK2
SCHEMBL7902199 0.75 PIK3CA (0.65) PIK3CAPIK3R1MTORPIK3CDJAK2
SCHEMBL3791135 0.75 PIK3CA (0.77) PIK3CAPIK3R1MTORPIK3CDJAK2
SCHEMBL539256 0.74 PIK3CA (0.78) PIK3CAPIK3R1MTORPIK3CDJAK2
SCHEMBL2377374 0.74 PIK3CA (0.68) PIK3CAPIK3R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010114494-A1 8-SUBSTITUTED-2-MORPHOLINO PURINES FOR USE AS PI3K AND/OR MTOR INHIBITORS IN THE TREATMENT OF PROLIFERATIVE DISORDERS S*BIO PTE LTD (SG) 2010-10-07 WO disclosed